Stockreport

Venture firms pour $101M into a biotech using the brain to fix the immune system [Yahoo! Finance]

Repare Therapeutics Inc. - Common Shares  (RPTX) 
PDF Having closed a nine-figure fundraising round, a newly launched biotechnology company hopes to rewire the immune system with drugs aimed at a special kind of nerve cell [Read more]